Sperm Is a Focus of Start-Ups Looking to Boost Fertility
By Fiorella Valdesolo,
WSJ Magazine
| 06. 08. 2022
“Where is the we?” It’s the question that was the driving force for Vida Delrahim and Ronit Menashe when they created WeNatal, a new brand of prenatal supplements that aims to be more inclusive. In the process of trying to conceive, couples often use the word we. We’re trying to get pregnant. We’re having trouble conceiving. We’re having a baby. But, as Delrahim and Menashe realized after their own individual struggles to conceive, despite all the we, much of the burden of fertility optimization continues to fall on women. It’s an imbalance that WeNatal and a number of other start-ups are starting to address.
In the quest for high-quality embryos and viable pregnancies, sperm is critical, says Toronto-based reproductive endocrinologist Dan Nayot, who is chief medical advisor for fertility supplement company Bird&Be. And good sperm is about both quality and quantity. In a routine semen analysis, Nayot generally looks at the volume of semen (a combination of seminal fluid and sperm); sperm concentration (how many millions of sperm per millimeter); sperm motility (how many are actually moving...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...